Literature DB >> 4043015

Reduction of rat hippocampal calcium-binding protein following commissural, amygdala, septal, perforant path, and olfactory bulb kindling.

K G Baimbridge, I Mody, J J Miller.   

Abstract

The calcium-binding protein (CaBP) content of the hippocampal formation was determined by radioimmunoassay in control and kindled rats. Kindling of a number of different sites resulted in a reduction in the CaBP content of the hippocampal formation, which was shown immunohistochemically to be restricted to the dentate granule cells and their processes. The maximum decline in CaBP varied with the different kindling sites: perforant path, 33%; commissural path, 32%; septum, 30%; amygdala, 18%; and olfactory bulbs, 15%. There were no changes in the CaBP content of the stimulated areas themselves. In cases where the kindling stimulus was delivered unilaterally (perforant path and amygdala), the maximum decrease in hippocampal CaBP was observed ipsilateral to the site of stimulation when the criterion for full kindling was established (six consecutive stage 5 motor seizures). Further kindling trials were required to produce a similar magnitude decrease in the CaBP content of the contralateral hippocampus. These observations are discussed both in relation to the possible role of CaBP in the establishment of a seizure response to kindling and also as a potential compensatory mechanism that may serve to overcome the epileptogenic effects of kindling.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043015     DOI: 10.1111/j.1528-1157.1985.tb05681.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

1.  Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis.

Authors:  H E Scharfman; J H Goodman; A L Sollas
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Mossy fibers are the primary source of afferent input to ectopic granule cells that are born after pilocarpine-induced seizures.

Authors:  Joseph P Pierce; Jay Melton; Michael Punsoni; Daniel P McCloskey; Helen E Scharfman
Journal:  Exp Neurol       Date:  2005-12       Impact factor: 5.330

Review 3.  Activity-dependent changes in voltage-dependent calcium currents and transmitter release.

Authors:  G A Lnenicka; S J Hong
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

4.  Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy.

Authors:  U V Nägerl; I Mody; M Jeub; A A Lie; C E Elger; H Beck
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

5.  Biochemical properties of metallothionein isoforms from bovine hippocampus.

Authors:  V K Paliwal; M Ebadi
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 6.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

Review 7.  Functional implications of seizure-induced neurogenesis.

Authors:  Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

8.  Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons.

Authors:  G Köhr; C E Lambert; I Mody
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

9.  Differential Ca2+ binding properties in the human cerebellar cortex: distribution of parvalbumin and calbindin D-28k immunoreactivity.

Authors:  A L Scotti; C Nitsch
Journal:  Anat Embryol (Berl)       Date:  1992

10.  Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus.

Authors:  Dawn S Carter; Anne J Harrison; Katherine W Falenski; Robert E Blair; Robert J DeLorenzo
Journal:  Epilepsy Res       Date:  2008-04-03       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.